Total Revenue
Thermo Fisher Scientific Total Revenue increased by 6.2% to $11.01B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.2%, from $10.36B to $11.01B. Over 3 years (FY 2021 to FY 2024), Total Revenue shows relatively stable performance with a 3.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates market expansion or higher demand, while a decrease may signal market saturation or competitive pressure.
Detailed definition
Total revenue represents the gross inflow of economic benefits arising from the ordinary operating activities of the com...
Peer comparison
Standard across all public companies; peers in the medical device and diagnostics sector typically show steady growth correlated with product adoption.
total_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.27B | $9.33B | $10.70B | $11.82B | $10.97B | $10.68B | $11.45B | $10.71B | $10.69B | $10.57B | $10.89B | $10.35B | $10.54B | $10.60B | $11.40B | $10.36B | $11.01B |
| QoQ Change | — | +0.6% | +14.7% | +10.4% | -7.2% | -2.7% | +7.2% | -6.5% | -0.2% | -1.1% | +3.0% | -5.0% | +1.9% | +0.5% | +7.5% | -9.0% | +6.2% |
| YoY Change | — | — | — | — | +18.3% | +14.4% | +7.0% | -9.4% | -2.6% | -1.0% | -4.9% | -3.4% | -1.4% | +0.2% | +4.7% | +0.2% | +6.2% |
Product Breakdown
| Segment | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Service revenues | $4.48B | $4.39B | $4.38B | $4.45B | $4.63B | $4.38B | $4.63B | $4.73B |
| Consumables | $4.37B | $4.33B | $4.36B | $4.38B | $4.52B | $4.35B | $4.68B | $4.72B |
| Instruments | $2.04B | $1.63B | $1.80B | $1.77B | $2.25B | $1.63B | $1.81B | $1.56B |
| Total | $10.89B | $10.35B | $10.54B | $10.60B | $11.40B | $10.36B | — | $11.01B |
Business Segments
| Segment | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Laboratory Products and Biopharma Services | — | — | — | — | — | — | $5.97B | $6.04B |
| Life Sciences Solutions | $2.47B | $2.29B | $2.36B | $2.39B | $2.60B | $2.34B | $2.59B | $2.64B |
| Analytical Instruments | $2.04B | $1.69B | $1.78B | $1.81B | $2.19B | $1.72B | $1.89B | $1.72B |
| Specialty Diagnostics | $1.11B | $1.11B | $1.12B | $1.13B | $1.16B | $1.15B | $1.17B | $1.14B |
| Laboratory Productsand Services | $5.72B | $5.72B | $5.76B | $5.74B | — | — | — | — |
| Total | $10.89B | $10.35B | $10.54B | $10.60B | $11.40B | $10.36B | — | $11.01B |
Laboratory Productsand Services was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.
Geographic Breakdown
| Segment | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| North America | $5.60B | $5.52B | $5.53B | $5.59B | $5.87B | $5.51B | $5.69B | $5.71B |
| Europe | $2.84B | $2.62B | $2.66B | $2.69B | $2.89B | $2.62B | $3.01B | $2.96B |
| Asia-Pacific | $2.07B | $1.86B | $1.97B | $1.92B | $2.20B | $1.89B | $2.01B | $1.97B |
| Other regions | $367.00M | $346.00M | $379.00M | $397.00M | $439.00M | $337.00M | $415.00M | $372.00M |
| Total | $10.89B | $10.35B | $10.54B | $10.60B | $11.40B | $10.36B | — | $11.01B |
Total Revenue at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's total revenue?
- Thermo Fisher Scientific (TMO) reported total revenue of $11.01B in Q1 2026.
- How has Thermo Fisher Scientific's total revenue changed year-over-year?
- Thermo Fisher Scientific's total revenue increased by 6.2% year-over-year, from $10.36B to $11.01B.
- What is the long-term trend for Thermo Fisher Scientific's total revenue?
- Over 3 years (2021 to 2024), Thermo Fisher Scientific's total revenue has grown at a 3.0% compound annual growth rate (CAGR), from $39.21B to $42.88B.
- What does total revenue mean?
- The total amount of money a company brings in from its primary business activities before any expenses.